Bothmer, Anne
Phadke, Tanushree
Barrera, Luis A.
Margulies, Carrie M
Lee, Christina S.
Buquicchio, Frank
Moss, Sean
Abdulkerim, Hayat S.
Selleck, William
Jayaram, Hariharan
Myer, Vic E.
Cotta-Ramusino, Cecilia
Article History
Received: 8 May 2016
Accepted: 11 November 2016
First Online: 9 January 2017
Competing interests
: A.B., T.P., L.A.B., C.M.M., C.S.L., F.B., S.M., H.S.A., W.S., H.J., V.E.M. and C.C-R. are current or former employees of and own options or shares of Editas Medicine, Inc. Editas Medicine is a company dedicated to using the CRISPR-Cas9 system to treating patients with genetic diseases. Patent applications were filed associated with results from this work.